Cargando…

Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis

BACKGROUND/OBJECTIVES: Implantable cardioverter defibrillators are used to prevent sudden cardiac death. The subcutaneous implantable cardioverter-defibrillator was newly developed to overcome the limitations of the conventional implantable cardioverter defibrillator-transvenous device. The subcutan...

Descripción completa

Detalles Bibliográficos
Autores principales: Araújo, Camilla Silva, Silva, Carla Liz Barbosa, Júnior, Antônio da Silva Menezes, Barbosa, Vinícius Araújo, de Almeida Laranjeira, Tiago, Fernandes, Joaquim Ferreira, Gonçalves, Lucas Cândido, Silva, Antonio Márcio Cordeiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Science Publishers 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615219/
https://www.ncbi.nlm.nih.gov/pubmed/34879809
http://dx.doi.org/10.2174/1573403X17666211208100151
_version_ 1784820373338980352
author Araújo, Camilla Silva
Silva, Carla Liz Barbosa
Júnior, Antônio da Silva Menezes
Barbosa, Vinícius Araújo
de Almeida Laranjeira, Tiago
Fernandes, Joaquim Ferreira
Gonçalves, Lucas Cândido
Silva, Antonio Márcio Cordeiro
author_facet Araújo, Camilla Silva
Silva, Carla Liz Barbosa
Júnior, Antônio da Silva Menezes
Barbosa, Vinícius Araújo
de Almeida Laranjeira, Tiago
Fernandes, Joaquim Ferreira
Gonçalves, Lucas Cândido
Silva, Antonio Márcio Cordeiro
author_sort Araújo, Camilla Silva
collection PubMed
description BACKGROUND/OBJECTIVES: Implantable cardioverter defibrillators are used to prevent sudden cardiac death. The subcutaneous implantable cardioverter-defibrillator was newly developed to overcome the limitations of the conventional implantable cardioverter defibrillator-transvenous device. The subcutaneous implantable cardioverter defibrillator is indicated for young patients with heart disease, congenital heart defects, and poor venous access, who have an indication for implantable cardioverter defibrillator without the need for anti-bradycardic stimulation. We aimed to compare the efficacy and complications of subcutaneous with transvenous implantable cardioverter-defibrillator devices. METHODOLOGY: A systematic review was conducted using different databases. The inclusion criteria were observational and clinical randomized trials with no language limits and no publication date limit that compared subcutaneous with transvenous implantable cardioverter-defibrillators. The selected patients were aged > 18 years with complex ventricular arrhythmia. RESULTS: Five studies involving 2111 patients who underwent implantable cardioverter defibrillator implantation were included. The most frequent complication in the subcutaneous device group was infection, followed by hematoma formation and electrode migration. For the transvenous device, the most frequent complications were electrode migration and infection. Regarding efficacy, the total rates of appropriate shocks were 9.04% and 20.47% in the subcutaneous and transvenous device groups, respectively, whereas inappropriate shocks to the subcutaneous and transvenous device groups were 11,3% and 10,7%, respectively. CONCLUSION: When compared to the transvenous device, the subcutaneous device had lower complication rates owing to lead migration and less inappropriate shocks due to supraventricular tachycardia; nevertheless, infection rates and improper shocks due to T wave oversensing were comparable for both devices CRD42021251569.
format Online
Article
Text
id pubmed-9615219
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Bentham Science Publishers
record_format MEDLINE/PubMed
spelling pubmed-96152192023-05-26 Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis Araújo, Camilla Silva Silva, Carla Liz Barbosa Júnior, Antônio da Silva Menezes Barbosa, Vinícius Araújo de Almeida Laranjeira, Tiago Fernandes, Joaquim Ferreira Gonçalves, Lucas Cândido Silva, Antonio Márcio Cordeiro Curr Cardiol Rev Article BACKGROUND/OBJECTIVES: Implantable cardioverter defibrillators are used to prevent sudden cardiac death. The subcutaneous implantable cardioverter-defibrillator was newly developed to overcome the limitations of the conventional implantable cardioverter defibrillator-transvenous device. The subcutaneous implantable cardioverter defibrillator is indicated for young patients with heart disease, congenital heart defects, and poor venous access, who have an indication for implantable cardioverter defibrillator without the need for anti-bradycardic stimulation. We aimed to compare the efficacy and complications of subcutaneous with transvenous implantable cardioverter-defibrillator devices. METHODOLOGY: A systematic review was conducted using different databases. The inclusion criteria were observational and clinical randomized trials with no language limits and no publication date limit that compared subcutaneous with transvenous implantable cardioverter-defibrillators. The selected patients were aged > 18 years with complex ventricular arrhythmia. RESULTS: Five studies involving 2111 patients who underwent implantable cardioverter defibrillator implantation were included. The most frequent complication in the subcutaneous device group was infection, followed by hematoma formation and electrode migration. For the transvenous device, the most frequent complications were electrode migration and infection. Regarding efficacy, the total rates of appropriate shocks were 9.04% and 20.47% in the subcutaneous and transvenous device groups, respectively, whereas inappropriate shocks to the subcutaneous and transvenous device groups were 11,3% and 10,7%, respectively. CONCLUSION: When compared to the transvenous device, the subcutaneous device had lower complication rates owing to lead migration and less inappropriate shocks due to supraventricular tachycardia; nevertheless, infection rates and improper shocks due to T wave oversensing were comparable for both devices CRD42021251569. Bentham Science Publishers 2022-05-26 2022-05-26 /pmc/articles/PMC9615219/ /pubmed/34879809 http://dx.doi.org/10.2174/1573403X17666211208100151 Text en © 2022 Bentham Science Publishers https://creativecommons.org/licenses/by-nc/4.0/ This is an open access article licensed under the terms of the Creative Commons Attribution-Non-Commercial 4.0 International Public License (CC BY-NC 4.0) (https://creativecommons.org/licenses/by-nc/4.0/), which permits unrestricted, non-commercial use, distribution and reproduction in any medium, provided the work is properly cited.
spellingShingle Article
Araújo, Camilla Silva
Silva, Carla Liz Barbosa
Júnior, Antônio da Silva Menezes
Barbosa, Vinícius Araújo
de Almeida Laranjeira, Tiago
Fernandes, Joaquim Ferreira
Gonçalves, Lucas Cândido
Silva, Antonio Márcio Cordeiro
Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis
title Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis
title_full Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis
title_fullStr Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis
title_full_unstemmed Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis
title_short Efficacy and Complications of Subcutaneous versus Conventional Cardioverter Defibrillators: A Systematic Review and Meta-analysis
title_sort efficacy and complications of subcutaneous versus conventional cardioverter defibrillators: a systematic review and meta-analysis
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9615219/
https://www.ncbi.nlm.nih.gov/pubmed/34879809
http://dx.doi.org/10.2174/1573403X17666211208100151
work_keys_str_mv AT araujocamillasilva efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis
AT silvacarlalizbarbosa efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis
AT juniorantoniodasilvamenezes efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis
AT barbosaviniciusaraujo efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis
AT dealmeidalaranjeiratiago efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis
AT fernandesjoaquimferreira efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis
AT goncalveslucascandido efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis
AT silvaantoniomarciocordeiro efficacyandcomplicationsofsubcutaneousversusconventionalcardioverterdefibrillatorsasystematicreviewandmetaanalysis